Jan 13, 2020 / 10:00PM GMT
Lisa Christine Gill - JP Morgan Chase & Co, Research Division - Senior Publishing Analyst
Good afternoon. My name is Lisa Gill. I'm the Healthcare Technology and Distribution Analyst with JPMorgan. It is with great pleasure this afternoon that I introduce AmerisourceBergen. With us is CEO, Steve Collis. We will take all questions across the hall in the Georgian room post the presentation. Steve?
Steven H. Collis - AmerisourceBergen Corporation - Chairman, President & CEO
Hi Lisa. Thank you, everyone, for attending. I was worried Sage presented before us and the room was jampacked, and almost everyone left, but I appreciate everyone who came to attend and fill up our chairs. So I thank you here, for being here. And the next slide is my cautionary note regarding forward-looking statements. Any of you can read, pass an ophthalmology exam, you have my great respect. So now I'll move on to my presentation.
AmerisourceBergen, yes, is $175 billion in revenue. We'll be hopefully getting close to $200 billion in revenue soon. That's quite a milestone. It
AmerisourceBergen Corp at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot